Zimmer Biomet entered into an exclusive global distribution agreement for CelgenTek Innovations’ N-Force Fixation System® and iN3 Cement.
This agreement allows healthcare professionals to directly administer N-Force Blue Bone Substitute Material (available in the U.S.) and iN3 Cement (available in the EU) directly through a fenestrated screw in a single integrated construct.
CelgenTek’s subsidiaries include Memphis, TN-based InnoVision and Shannon, Ireland-based CelgenTek, manufacturer of the N-Force Fixation System and iN3 Cement. N-Force is FDA-cleared in the U.S. and EU, while iN3 cement is available in the EU.
Zimmer Biomet entered into an exclusive global distribution agreement for CelgenTek Innovations' N-Force Fixation System® and iN3 Cement.
This agreement allows healthcare professionals to directly administer N-Force Blue Bone Substitute Material (available in the U.S.) and iN3 Cement (available in the EU) directly through a fenestrated screw...
Zimmer Biomet entered into an exclusive global distribution agreement for CelgenTek Innovations’ N-Force Fixation System® and iN3 Cement.
This agreement allows healthcare professionals to directly administer N-Force Blue Bone Substitute Material (available in the U.S.) and iN3 Cement (available in the EU) directly through a fenestrated screw in a single integrated construct.
CelgenTek’s subsidiaries include Memphis, TN-based InnoVision and Shannon, Ireland-based CelgenTek, manufacturer of the N-Force Fixation System and iN3 Cement. N-Force is FDA-cleared in the U.S. and EU, while iN3 cement is available in the EU.
Copy to clipboard 
